- call +1-201-465-4211
- email sales@mrinsights.biz
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Scope of the Report:
North America is the largest supplier of Plasma Fractionation, with production revenue market share about 60%, and the sales market share is 44% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20% in 2015. China is an important market of Plasma Fractionation in Asia, accounting for 11% production revenue market share and 12% sales revenue market share of global market in 2015.
Japan has production revenue market share of 5% and sales revenue market share of 7% nearly in 2015. The local production can meet most local demand, and there is a small amount of imports.
Baxter, CSL, Grifols are the leaders of the industry, with 65% market share in 2015, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
The worldwide market for Plasma Fractionation is expected to grow at a CAGR of roughly 10.6% over the next five years, will reach 52800 million US$ in 2024, from 28900 million US$ in 2019, according to a new study.
This report focuses on the Plasma Fractionation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Albumin
Immune Globulin
Coagulation Factor
Market Segment by Applications, can be divided into
Immunity
Therapy
Surgery
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Fractionation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma Fractionation, with price, sales, revenue and global market share of Plasma Fractionation in 2017 and 2018.
Chapter 3, the Plasma Fractionation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Fractionation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Plasma Fractionation market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Plasma Fractionation sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Plasma Fractionation Introduction
1.2 Market Analysis by Type
1.2.1 Albumin
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.3 Market Analysis by Applications
1.3.1 Immunity
1.3.2 Therapy
1.3.3 Surgery
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Business Overview
2.1.2 Plasma Fractionation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 CSL
2.2.1 Business Overview
2.2.2 Plasma Fractionation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CSL Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Grifols
2.3.1 Business Overview
2.3.2 Plasma Fractionation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Grifols Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Octapharma
2.4.1 Business Overview
2.4.2 Plasma Fractionation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Octapharma Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 BPL
2.5.1 Business Overview
2.5.2 Plasma Fractionation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BPL Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Kedrion
2.6.1 Business Overview
2.6.2 Plasma Fractionation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kedrion Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mitsubishi Tanabe
2.7.1 Business Overview
2.7.2 Plasma Fractionation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mitsubishi Tanabe Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 CBOP
2.8.1 Business Overview
2.8.2 Plasma Fractionation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CBOP Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 RAAS
2.9.1 Business Overview
2.9.2 Plasma Fractionation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 RAAS Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Hualan Bio
2.10.1 Business Overview
2.10.2 Plasma Fractionation Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hualan Bio Plasma Fractionation Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Plasma Fractionation Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Plasma Fractionation Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Plasma Fractionation Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Plasma Fractionation Manufacturer Market Share in 2018
3.3.2 Top 6 Plasma Fractionation Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Plasma Fractionation Market Analysis by Regions
4.1 Global Plasma Fractionation Sales, Revenue and Market Share by Regions
4.1.1 Global Plasma Fractionation Sales and Market Share by Regions (2014-2019)
4.1.2 Global Plasma Fractionation Revenue and Market Share by Regions (2014-2019)
4.2 North America Plasma Fractionation Sales and Growth Rate (2014-2019)
4.3 Europe Plasma Fractionation Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Plasma Fractionation Sales and Growth Rate (2014-2019)
4.5 South America Plasma Fractionation Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Plasma Fractionation Sales and Growth Rate (2014-2019)
5 North America Plasma Fractionation by Country
5.1 North America Plasma Fractionation Sales, Revenue and Market Share by Country
5.1.1 North America Plasma Fractionation Sales and Market Share by Country (2014-2019)
5.1.2 North America Plasma Fractionation Revenue and Market Share by Country (2014-2019)
5.2 United States Plasma Fractionation Sales and Growth Rate (2014-2019)
5.3 Canada Plasma Fractionation Sales and Growth Rate (2014-2019)
5.4 Mexico Plasma Fractionation Sales and Growth Rate (2014-2019)
6 Europe Plasma Fractionation by Country
6.1 Europe Plasma Fractionation Sales, Revenue and Market Share by Country
6.1.1 Europe Plasma Fractionation Sales and Market Share by Country (2014-2019)
6.1.2 Europe Plasma Fractionation Revenue and Market Share by Country (2014-2019)
6.2 Germany Plasma Fractionation Sales and Growth Rate (2014-2019)
6.3 UK Plasma Fractionation Sales and Growth Rate (2014-2019)
6.4 France Plasma Fractionation Sales and Growth Rate (2014-2019)
6.5 Russia Plasma Fractionation Sales and Growth Rate (2014-2019)
6.6 Italy Plasma Fractionation Sales and Growth Rate (2014-2019)
7 Asia-Pacific Plasma Fractionation by Country
7.1 Asia-Pacific Plasma Fractionation Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Plasma Fractionation Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Plasma Fractionation Revenue and Market Share by Country (2014-2019)
7.2 China Plasma Fractionation Sales and Growth Rate (2014-2019)
7.3 Japan Plasma Fractionation Sales and Growth Rate (2014-2019)
7.4 Korea Plasma Fractionation Sales and Growth Rate (2014-2019)
7.5 India Plasma Fractionation Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Plasma Fractionation Sales and Growth Rate (2014-2019)
8 South America Plasma Fractionation by Country
8.1 South America Plasma Fractionation Sales, Revenue and Market Share by Country
8.1.1 South America Plasma Fractionation Sales and Market Share by Country (2014-2019)
8.1.2 South America Plasma Fractionation Revenue and Market Share by Country (2014-2019)
8.2 Brazil Plasma Fractionation Sales and Growth Rate (2014-2019)
8.3 Argentina Plasma Fractionation Sales and Growth Rate (2014-2019)
8.4 Colombia Plasma Fractionation Sales and Growth Rate (2014-2019)
9 Middle East and Africa Plasma Fractionation by Countries
9.1 Middle East and Africa Plasma Fractionation Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Plasma Fractionation Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Plasma Fractionation Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Plasma Fractionation Sales and Growth Rate (2014-2019)
9.3 Turkey Plasma Fractionation Sales and Growth Rate (2014-2019)
9.4 Egypt Plasma Fractionation Sales and Growth Rate (2014-2019)
9.5 Nigeria Plasma Fractionation Sales and Growth Rate (2014-2019)
9.6 South Africa Plasma Fractionation Sales and Growth Rate (2014-2019)
10 Global Plasma Fractionation Market Segment by Type
10.1 Global Plasma Fractionation Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Plasma Fractionation Sales and Market Share by Type (2014-2019)
10.1.2 Global Plasma Fractionation Revenue and Market Share by Type (2014-2019)
10.2 Albumin Sales Growth and Price
10.2.1 Global Albumin Sales Growth (2014-2019)
10.2.2 Global Albumin Price (2014-2019)
10.3 Immune Globulin Sales Growth and Price
10.3.1 Global Immune Globulin Sales Growth (2014-2019)
10.3.2 Global Immune Globulin Price (2014-2019)
10.4 Coagulation Factor Sales Growth and Price
10.4.1 Global Coagulation Factor Sales Growth (2014-2019)
10.4.2 Global Coagulation Factor Price (2014-2019)
11 Global Plasma Fractionation Market Segment by Application
11.1 Global Plasma Fractionation Sales Market Share by Application (2014-2019)
11.2 Immunity Sales Growth (2014-2019)
11.3 Therapy Sales Growth (2014-2019)
11.4 Surgery Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Plasma Fractionation Market Forecast (2019-2024)
12.1 Global Plasma Fractionation Sales, Revenue and Growth Rate (2019-2024)
12.2 Plasma Fractionation Market Forecast by Regions (2019-2024)
12.2.1 North America Plasma Fractionation Market Forecast (2019-2024)
12.2.2 Europe Plasma Fractionation Market Forecast (2019-2024)
12.2.3 Asia-Pacific Plasma Fractionation Market Forecast (2019-2024)
12.2.4 South America Plasma Fractionation Market Forecast (2019-2024)
12.2.5 Middle East and Africa Plasma Fractionation Market Forecast (2019-2024)
12.3 Plasma Fractionation Market Forecast by Type (2019-2024)
12.3.1 Global Plasma Fractionation Sales Forecast by Type (2019-2024)
12.3.2 Global Plasma Fractionation Market Share Forecast by Type (2019-2024)
12.4 Plasma Fractionation Market Forecast by Application (2019-2024)
12.4.1 Global Plasma Fractionation Sales Forecast by Application (2019-2024)
12.4.2 Global Plasma Fractionation Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Plasma Fractionation Picture
Table Product Specifications of Plasma Fractionation
Figure Global Sales Market Share of Plasma Fractionation by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
